1 to 6 of 6 literature results

• Array-CGH identifies cyclin D1 and UBCH10 amplicons in anaplastic thyroid carcinoma.

  Anaplastic thyroid cancer (ATC) is a rare but highly aggressive disease with largely unexplained etiology and molecular pathogenesis. In this study, w…

  Authors: Jia-Jing Lee, Amy Y M Au, Theodoros Foukakis, Michela Barbaro, Nimrod Kiss, Roderick Clifton-Bligh, Johan Staaf, Ake Borg, Leigh Delbridge, Bruce G Robinson,…

  Source: Endocrine-related cancer. 2008 Sep

  View Full Text

• A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery.

  Oncogenic osteomalacia is a rare condition characterized by a low serum phosphate, reduced tubular reabsorption of phosphate and a low or inappropriat…

  Authors: Marianne S Elston, Inge J Stewart, Roderick Clifton-Bligh, John V Conaglen

  Source: Bone. 2007 Jan

  View Full Text

• Neonatal hypercalcemia due to polymorphisms of the calcium sensing receptor.

  Familial hypocalciuric hypercalcemia (FHH) is known to be caused by heterozygous inactivating mutations of the calcium sensing receptor (CaSR) gene. W…

  Authors: Michelle M Jack, Monique L Stone, Roderick Clifton-Bligh

  Source: Journal of pediatric endocrinology & metabolism : JPEM. 2009 Jun

  View Full Text

• The Ras effector NORE1A is suppressed in follicular thyroid carcinomas with a PAX8-PPARgamma fusion.

  CONTEXT: The Ras effector NORE1A (RASSF5A) is a putative tumor suppressor and is inactivated in several human cancers. NORE1A has not been studied in …

  Authors: Theodoros Foukakis, Amy Y M Au, Göran Wallin, Janos Geli, Lars Forsberg, Roderick Clifton-Bligh, Bruce G Robinson, Weng-Onn Lui, Jan Zedenius, Catharina Larsson

  Source: The Journal of clinical endocrinology and metabolism. 2006 Mar

  View Full Text

• Detection of the PAX8-PPAR gamma fusion oncogene in both follicular thyroid carcinomas and adenomas.

  Chromosomal translocations encoding fusion oncoproteins are common in hematological malignancies, sarcomas, and papillary thyroid carcinomas. A recent…

  Authors: Linda Cheung, Marinella Messina, Anthony Gill, Adele Clarkson, Diana Learoyd, Leigh Delbridge, John Wentworth, Jeanette Philips, Roderick Clifton-Bligh, Bruce G Robinson

  Source: The Journal of clinical endocrinology and metabolism. 2003 Jan

  View Full Text

• Clinical case seminar: Fibroblast growth factor 23: a new clinical marker for oncogenic osteomalacia.

  The phosphate-wasting condition, oncogenic osteomalacia, is problematic to diagnose and manage clinically due to difficulty in locating the causative …

  Authors: Anne E Nelson, Roderick Clifton Bligh, Michiko Mirams, Anthony Gill, Amy Au, Adele Clarkson, Harald Jüppner, Stephen Ruff, Paul Stalley, Richard A Scolyer,…

  Source: The Journal of clinical endocrinology and metabolism. 2003 Sep

  View Full Text